Mexico Introduces Pfizer’s COVID Vaccine for Use in Children 12 Years and Older + More • Protecting Children’s Health

Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

Mexico Launches Pfizer’s COVID Vaccine for Use in Children 12 Years and Older

Reuters via Yahoo News reports:

The Mexican health regulator gives permission to the drug maker in the United States Pfizer Inc.’s COVID-19 vaccine is for use by children 12 and older, Deputy Health Minister Hugo Lopez-Gatell said on Twitter on Thursday.

“This is the first COVID-19 the vaccine is allowed for the youth in our country, ”he said.

Who Urges Whole Vaccinated People to Continue to Wear a Mask as Delta COVID Variant Spreads

Reported by CNBC:

The World Health Organization on Friday urged fully vaccinated people to continue to wear a mask, social distance and do more. COVID-19 pandemic survival measures as the most contagious delta variant quickly spread around the world.

“People don’t feel safe because they have two doses. They still have to protect themselves, ”said Dr. Mariangela Simao, WHO’s assistant director-general for access to medicines and health products, said in a news briefing.

Israel’s Delta Variant Outbreak Infects Some Vaccinated Adults

The Wall Street Journal reports:

Nearly half of adults are affected by an onset of the Delta variety COVID-19 of Israel is fully appointed to Pfizer Vaccine Inc., urging the government to also put in place a necessary vaccine and other measures to prevent the most transferable filter.

The Delta variety, which is first appeared in India in late 2020 and also known as B.1.617.2, is now found in more than 70 countries. In the US, public health experts expect it to soon become the predominant sin.

Latest Presentation of CDC Data VAERS Reported Injury Injuries Exceeds 7,000 Ages 12 to 17 Following COVID Vaccine

The Defender reports:

Data released today shows that between Dec. 14, 2020 and June 18, 2021, a total 387,087 total adverse events reported to VAERS, including 6,113 died – an increase of 120 who died last week. There are 31,240 severe injury reports, up to 1,369 compared to last week.

This week’s data for 12- to 17-year-olds are shown: 7,294 general adverse events, including 423 marked as serious and nine were reported dead between 12- to 17-years-old. Four deaths (or 44%) were heart-related and three were sudden, unexplained deaths.

Stocks of mRNA Vaccine Manufacturers Hit Between Possible Link to Crazy Heart Conditions

Yahoo Finance reports:

BioNTech stocks, Pfizer and Modern, which produced COVID-19 mRNA vaccine, fell amid news that jabs may be linked to rare heart inflammation in young people.

An advisory panel at the Centers for Disease Control and Prevention (CDC) has a “likely association” between young people who have received vaccines and cases of myocarditis and pericarditis, but it adds that the benefits outweigh the risks.

Some British Olympic Athletes Refuse to Have COVID Vaccine Over Fears of Site Impact

The Guardian reports:

British athletes who do not want to be vaccinated COVID-19 before making the Tokyo Olympics more on performance -related fears than a anti-vax stand, the Keeper understood.

the British Olympic Association remains confident that almost all 370 or more Olympians there were two jabs before they flew to Japan, with “very little” left unconvinced.

Houston Hospital Employee Says He Takes Advantage of Not Getting Vaccines: ‘Don’t Take My Choice’

CNN reported:

An ultrasound technologist says he was discharged from a Houston hospital because he could not be vaccinated against coronavirus CNN said Wednesday, “I don’t want to work for people like that. Don’t take my pick.”

LaTricia Blank worked at the Methodist hospital in Houston for eight and a half years. He loves his job, his patients and the people he works with, he said.

But the Houston Methodist on March 31 became the first leading health care system in the nation to mandate the COVID-19 vaccination. More than 100 employees have sued but a judge recently side of the hospital system. Employees appealed the judge’s decision.

Actor Lakis Lazopoulos Suffers Blood Clot After Taking 2nd Pfizer Vaccine

MA News reports:

The famous Greekmactor Lakis Lazopoulos was quickly taken to the hospital carrying a blood to blood a few days after handling coronavirus VACCINE

Speaking to the newspaper “Nea”, he revealed that on Saturday “I woke up with a heavy feeling in my leg, which made it difficult to move. I called my friend, doctor George Papatheou and was told to go and see him. me. He decided that I would go to Ygeia hospital. I went, tested and made sure I had stroke. It was a little cloth, but it was missing at first. ”

Biden Urges More People to Get the COVID Vaccine: ‘Do It.’

The News & Observer reports:

President Joe Biden visited a vaccination site in Raleigh, NC on June 24, 2021, to encourage people to get the COVID vaccine. He met with forward workers and volunteers at the Green Road Community Center.

Health Officials Concerned Over Myocarditis Concerns Increase Vaccine Doubts

WBRC Channel 6 Birmingham reports:

Local health officials are concerned The latest known to the CDC linking COVID-19 vaccine to rare heart conditions, myocarditis, there may be increased skepticism about the vaccine among parents.

The CDC reports there are 226 confirmed cases of the heart condition, myocarditis, linked to the COVID-19 vaccine. Officials say the concern is particularly prevalent among men under the age of 30, but local health officials say it is still very rare and parents should not be prevented from vaccinating their children.

COVID: German Scientists Learn How to Prevent Blood Vaccines

The KHMER Times reports:

German scientists believe they may be working on a way to prevent vector -based vaccines from causing the phenomenon. blood to blood.

German scientists believe they are working on why vector -based vaccines are preferred AstraZeneca and Johnson and Johnson’s Janssen causes a rare blood type in some people. And in their minds they know how to adapt the vaccine to prevent the blood from breaking down.

Delta Plus: As US Grapples With a Distinctive Delta, India Raises Alarm on a New COVID Strain That Changes It

CBS News reports:

Doctors and epidemiologists are closely watching the rise of another coronavirus another found in nearly a dozen countries, including the US Concern that the so -called Delta Plus variant – a mutation of now-widespread Delta offense The first found in India – could be more contagious and cause more serious health problems than other strains which prompted Indian officials last week to mark it as a “variety of concern.”

But while the rapid spread of the strain, and India’s disease experience with the original Delta strain, has alarmed the wider country, epidemiologists here and abroad say even more data is needed before providing the more caution around the world about Delta Plus.

Health 202: Don’t Expect Other Vaccines to ‘Stop’ Myocarditis Cases

The Washington Post via MSN reports:

The Centers for Disease Prevention and Prevention is getting even higher careful approach of those coronavirus vaccines if they are temporarily discontinued Johnson and Johnson shots earlier this year.

But now, as the agency counts hundreds of reports inflammation of the heart in young adults, there is more discretion going forward without changes to official vaccine recommendations.

German Lab, J&J Still Hashes COVID Vaccine Partnership Details

Reuters reported via MSN:

A scientist investigating is rare blood to blood possibly linked to AstraZeneca’s and Johnson and Johnson’s COVID-19 vaccines have not yet begun a planned partnership with the U.S. company, he said, as talks continue about their research deal.

Andreas Greinacher, an expert in pharmacology at Greifswald University in Germany, is studying the suppression of low blood platelets in people who have been vaccinated with the AstraZeneca vaccine.

In April, when a riot broke out among some people getting a shot of J&J, Greinacher announced that his lab would work with the U.S. company to investigate the causes. J&J, whose shot relies on technology similar to AstraZeneca’s, confirmed it is “exploring a potential collaboration.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *